After a decade of focused investment in TB innovation, a promising pipeline of new tools is in development. New drugs, diagnostics, and eventually a vaccine could vastly improve the way the world responds to TB, but more research and development is needed to ensure that these tools are fast acting, accessible, affordable, and simple to use. Our goal is to accelerate a reduction in global TB incidence.
Read more.